Mehdi Shahidi
Consulente / Consigliere presso Medicxi Ventures (Jersey) Ltd.
Provenienza dei contatti di primo grado di Mehdi Shahidi
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.
22
| Private Company | Investment Managers | 22 |
Aivivo Ltd.
 Aivivo Ltd. Packaged SoftwareTechnology Services Aivivo Ltd. engages in the provision of systems pharmacology platform powered by artificial intelligence (AI) to accelerate drug discovery. The company was founded by Peyman Gifani and is headquartered in Cambridge, the United Kingdom.
1
| Holding Company | Packaged Software | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mehdi Shahidi tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Founder Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
| Imperial College London | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| COMPUGEN LTD. | Biotechnology | Chairman Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rebalance (Cambridge) Ltd.
 Rebalance (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Rebalance (Cambridge) Ltd. provides research and experimental development on biotechnology. The company was founded on December 6, 2016 and is headquartered in Hatfield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Human Antibody Factory Ltd.
 Human Antibody Factory Ltd. BiotechnologyHealth Technology Human Antibody Factory Ltd. provides research and experimental development on biotechnology. The company was founded by David John Grainger and is headquartered in Hatfield, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stx Pharma Ltd. | Director/Board Member Founder | ||
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Critical Pressure Ltd.
 Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member Director/Board Member | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Janpix Holdings, Inc.
 Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kaerus Bioscience Ltd. | Chairman Director/Board Member | ||
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Index Ventures (UK) LLP | Investment Managers | Private Equity Investor Private Equity Investor | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
Inhibitaxin Ltd.
 Inhibitaxin Ltd. BiotechnologyHealth Technology Inhibitaxin Ltd. engages in research and development on biotechnology. The company was founded by Simon Lempriere Westbrook and Kevin S. Johnson in 2013 and is headquartered in Kent, the United Kingodm. | Biotechnology | Founder Director/Board Member | |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
Stealthyx Therapeutics Ltd.
 Stealthyx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Stealthyx Therapeutics Ltd. operates drug delivery system technology. The company was founded by Yuti Chernajovsky and Eileen Janis Anderson in 2002 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Morphogen-IX Ltd.
 Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder | |
XO1 Ltd.
 XO1 Ltd. Medical/Nursing ServicesHealth Services XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom. | Medical/Nursing Services | Founder Founder | |
UltraHuman Ltd.
 UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Index Venture Growth I (Jersey) LP | Corporate Officer/Principal | ||
| GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member | |
KdT Ventures LLC
 KdT Ventures LLC Investment ManagersFinance KdT Ventures LLC (KdT Ventures) is a venture capital firm founded in 2017 by Andrew Cain McClary. The firm is headquartered in Austin, Texas. | Investment Managers | Consultant / Advisor | |
Sanome
 Sanome BiotechnologyHealth Technology Part of Sanome Ltd, Sanome operates as a British biotechnology company that develops at-home health monitoring tools. The company is based in Cambridge, UK. The company was founded by Benedikt von Thüngen, Marc Philippe Camille van der Schee. Benedikt von Thüngen has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Exogene Ltd.
 Exogene Ltd. Packaged SoftwareTechnology Services Exogene Ltd. develops an artificial intelligence machine learning platform to discover cell therapies for cancer immunotherapies. The company is based in Oxford, UK. The British company was founded by Andrea Mambrini and Federico Paoletti, with Federico Paoletti serving as CEO since incorporation. | Packaged Software | Consultant / Advisor | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Egalet A/S
 Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Ochre Bio Ltd.
 Ochre Bio Ltd. Pharmaceuticals: MajorHealth Technology Ochre Bio Ltd. is a biotechnology company based in Headington, UK. Ochre Bio is focused on developing RNA medicines for chronic liver diseases. The British company uses deep phenotyping, precision RNA medicine, and testing in live human donor livers to develop therapies for important liver health challenges. The company's goal is to develop therapies that increase donor liver supply and reduce cirrhosis complications. The company was founded by Quin Wills and the CEO is Jack O'Meara. | Pharmaceuticals: Major | Consultant / Advisor | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
Orexia Therapeutics Ltd.
 Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Orexia Ltd. develop orally administered orexin positive modulators for the treatment of neurological diseases. The company was founded on October 5, 2018 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 28 |
| Stati Uniti | 12 |
| Svizzera | 5 |
| Paesi Bassi | 4 |
| Danimarca | 3 |
Settori
| Health Technology | 34 |
| Commercial Services | 8 |
| Finance | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 167 |
| Founder | 33 |
| Corporate Officer/Principal | 33 |
| Chairman | 29 |
| Private Equity Investor | 25 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Michèle Ollier | 40 |
| Francesco de Rubertis | 36 |
| David Grainger | 29 |
| Giuseppe Zocco | 26 |
| Sanford Zweifach | 22 |
| Kevin Johnson | 22 |
| Alasdair Thong | 15 |
| Giovanni Mariggi | 11 |
| Trevor Baglin | 8 |
| Nicholas Williams | 4 |
| Benjamin Perry | 4 |
| Matthew Lumley | 4 |
| Thibaud Portal | 3 |
| Jemila Houacine | 2 |
- Borsa valori
- Insiders
- Mehdi Shahidi
- Connessioni Società
